Cadinha & Co’s iShares Biotechnology ETF IBB Stock Holding History

Cadinha & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,110	Closed	-$759K	–	133
2017 Q4	$759K	Buy	+7,110	New	+$760K	0.1%	72

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cadinha & Co's IBB Position: Q1 2018 in Review

Cadinha & Co sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 7,110 shares — an estimated $759K sold.

Cadinha & Co first reported a position in IBB in Q4 2017 and held it in 1 quarter. The position peaked at $759K in Q4 2017. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

Cadinha & Co reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
Cadinha & Co sold 7,110 iShares Biotechnology ETF shares in Q1 2018, an estimated $759K.
Cadinha & Co first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 1 quarter.
Cadinha & Co's iShares Biotechnology ETF position peaked at $759K in Q4 2017.
608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on Cadinha & Co's 13F filing for Q1 2018, filed 10 May 2018.